Arcutis Biotherapeutics, Inc. (ARQT)

Arcutis Biotherapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Nov 3, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	3,033	1,630	305	901	1,043	1,225
Market Cap Growth	173.41%	434.82%	-66.18%	-13.58%	-14.88%	-
Enterprise Value	2,956	1,508	283	626	681	1,039
Last Close Price	24.76	13.93	3.23	14.80	20.74	28.13
PS Ratio	9.84	8.30	5.11	244.56	-	-
PB Ratio	18.84	10.35	3.44	4.30	3.50	4.53
P/TBV Ratio	21.25	11.01	3.71	4.45	3.50	4.53
EV/Sales Ratio	9.30	7.67	4.75	169.88	-	-
Debt / Equity Ratio	0.72	0.70	2.32	0.97	0.26	0.02
Asset Turnover	0.79	0.57	0.15	0.01	-	-
Inventory Turnover	1.75	1.38	0.48	-	-	-
Quick Ratio	3.07	3.72	6.38	11.06	11.61	12.61
Current Ratio	3.50	4.14	7.08	11.57	12.09	12.96
Return on Equity (ROE)	-28.17%	-113.76%	-175.79%	-122.80%	-72.62%	-72.93%
Return on Assets (ROA)	-5.91%	-23.25%	-38.12%	-43.97%	-36.55%	-42.14%
Return on Capital (ROIC)	-7.51%	-28.52%	-42.64%	-47.89%	-39.67%	-45.26%
Earnings Yield	-1.46%	-8.59%	-85.99%	-34.55%	-19.78%	-11.07%
FCF Yield	-1.10%	-6.89%	-81.18%	-28.63%	-16.84%	-9.25%
Buyback Yield / Dilution	-11.93%	-74.53%	-25.94%	-11.39%	-38.52%	-1835.11%

Updated Oct 28, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q